Oncolibrary

Sep 1, 2025, 18:26

Emre Yekedüz: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

The congress is free to attend.
Register via the link.

Co-Chair of VIRO

Images Name

Rana McKay
Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center

As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on
“Future Directions: Emerging Agents and Combinations.”

She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Emre Yekedüz

Dr. Yekedüz is an Associate Professor of Medical Oncology at Ankara University in Turkey.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Dr. Yekedüz will present on “The Current State of Renal Oncology in Turkey.” His talk will include:

An overview of renal cancer epidemiology and management practices in Turkey.
Challenges and innovations shaping renal oncology care within the region.
Insights from ongoing clinical research and therapeutic developments.
Prospects for collaboration and future advancements in Turkish renal oncology.

With a strong commitment to clinical excellence and research, Dr. Yekedüz highlights a focused and region-specific perspective aiming to elevate renal cancer care and research.

Global Voices in Renal Oncology (VIRO) 2025